Exelixis Reports Preliminary Financial Results for Fiscal Year 2024, Offers Financial Guidance for 2025, and Highlights Key Priorities and Milestones Ahead
Exelixis Announces Preliminary Fiscal Year 2024 Financial Results, Provides 2025 Financial Guidance and Outlines Key Priorities and Milestones for 2025 – Cabozantinib franchise achieves approximately $1.805 billion in preliminary U.S. net product revenues for fiscal year 2024 – – Fiscal year 2025 net product revenues guidance of $1.95 billion – $2.05 billion – – Presentation […]
Australian Oilseeds Unveils Financial Results for Fiscal Year 2024
Australian Oilseeds Announces Fiscal 2024 Financial Results Australian Oilseeds Holdings Ltd. COOTAMUNDRA, Australia, Dec. 05, 2024 (GLOBE NEWSWIRE) — Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (the “Company”) (NASDAQ: COOT) today announced financial results for its fiscal year ended June 30, 2024. Fiscal 2024 Financial Highlights Compared to Prior Year Sales revenue increased […]